Tetec Tissue Engineering Technologies AG

10 patents currently held · Updated Nov 14, 2026

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 3 name spellings.

Ending by 2030

Apr 2029

Next term end

When these terms end

5 yrs10 yrs20 yrs

Held patents by the year their term ends

20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.

1 fee due Jan 14, 2027
The maintenance fee for Methods of Determining Chondrocytes (US 9,080,213) comes due Jan 14, 2027. Unpaid by Jul 14, 2027, it lapses early.
1 fee due Mar 5, 2027
The maintenance fee for Production of Materials Having an Anisotropic Structure (US 11,744,923) comes due Mar 5, 2027. Unpaid by Sep 7, 2027, it lapses early.
1 fee due Jul 21, 2027
The maintenance fee for Identity and Purity of Tissue Biopsies (US 10,539,574) comes due Jul 21, 2027. Unpaid by Jan 21, 2028, it lapses early.
2 fees due Sep 3 to 29, 2027 · next Sep 3

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 10 of 10

Patent	Title	Status	Expires	Confidence
US 9,744,218	Multi-Chamber Applicator for Gelatin Solution In force Term ends Apr 20, 2029 · High confidence	In force	Term ends Apr 20, 2029	High confidence
US 9,295,751	Use of Gelatin and a Cross-Linking Agent for Producing Cross-Linking Medical Glues In force Term ends Jul 1, 2029 · High confidence	In force	Term ends Jul 1, 2029	High confidence
US 8,637,081	Use of Gelatin and a Cross-Linking Agent for Producing a Cross-Linking Therapeutic Composition In force Term ends Aug 6, 2029 · High confidence	In force	Term ends Aug 6, 2029	High confidence
US 9,080,213	Methods of Determining Chondrocytes In force Term ends Jul 27, 2031 · High confidence	In force	Term ends Jul 27, 2031	High confidence
US 9,649,816	Production of materials having an anisotropic structure In force Term ends Dec 10, 2032 · High confidence	In force	Term ends Dec 10, 2032	High confidence
US 10,576,694	Production of Materials Having an Anisotropic Structure In force Term ends Dec 10, 2032 · High confidence	In force	Term ends Dec 10, 2032	High confidence
US 11,744,923	Production of Materials Having an Anisotropic Structure In force Term ends Feb 13, 2034 · High confidence	In force	Term ends Feb 13, 2034	High confidence
US 10,539,574	Identity and Purity of Tissue Biopsies In force Term ends Sep 11, 2035 · High confidence	In force	Term ends Sep 11, 2035	High confidence
US 11,065,364	Combination with Albumin, in Particular for Treating a Cartilage Defect In force Term ends Sep 15, 2037 · High confidence	In force	Term ends Sep 15, 2037	High confidence
US 11,324,855	Cell-free Combination, Hydrogel-like Material or Hydrogel and Use of Same In force Term ends Apr 24, 2038 · High confidence	In force	Term ends Apr 24, 2038	High confidence

Also on record, not counted in the 10: 6 lapsed for an unpaid fee · 3 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Export every term end as CSV · Pro

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

6 no status recorded

List them